Receptor tyrosine kinases (RTKs) are found at high levels on various cancer cells. A protein, Herceptin, has been found to bind to an RTK known as HER2. This information can now be utilized in breast cancer treatment if which of the following is true?
A) If Herceptin is found in the breast lymph nodes of the patient.
B) If HER2, administered by injection, is in sufficient concentration.
C) If the patient's cancer cells have detectable HER2.
D) If the patient's genome codes for the HER2 receptor.
E) If the patient's genome codes for the manufacture of Herceptin.
